HR
Healthcare Realty Trust Incorporated
Healthcare Realty Trust Incorporated historical holders
total: 1
Pzena Investment Management Healthcare Realty Trust Incorporated transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2024 Q3
- Held for:
- 7 quarters
- Latest activity:
- 2026 Q1
Richard Pzena has been an institutional investor in Healthcare Realty Trust Incorporated (HR) since 2024 Q3. According to 2026 Q1 report, Richard Pzena holds 2,225,430 shares with a market value of roughly $37.81M representing 0.12% of their equity portfolio. The fund/company first acquired HR in 2024 Q3, initially purchasing about 2.23M shares. Since the initial investment, Pzena Investment Management has made 2 more transactions in this position.
Does Richard Pzena still hold HR?
Yes, Richard Pzena continues to hold Healthcare Realty Trust Incorporated (HR). According to their 2026 Q1 report, they maintain a position of 2,225,430 shares valued at approximately $37.81M, representing 0.12% of their equity portfolio.
When did Richard Pzena first invest in HR?
Richard Pzena first invested in Healthcare Realty Trust Incorporated (HR) in 2024 Q3 at the reported quarter-end price of $18.15 per share, acquiring 2,225,430 shares in their initial purchase.
What is Richard Pzena's average cost basis for HR?
Based on historical transaction data, Richard Pzena's estimated cost basis for Healthcare Realty Trust Incorporated (HR) is approximately $18.15 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $18.15
- Weighted AVG sell price:
- $16.99
HR transactions history by Pzena Investment Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.12%
|
2,225,430
|
$16.99
|
$37,810,056
|
-0.02% (-359)
|
-0%
|
|
2024 Q4
|
0.13%
|
2,225,789
|
$16.95
|
$37,727,124
|
+0.02% (+359)
|
+0%
|
|
2024 Q3
|
0.13%
|
2,225,430
|
$18.15
|
$40,391,555
|
new
|
+0.13%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.